According to a report by The Times of India (TOI), a 28-year-old man with acute pulmonary thromboembolism (PE) has been successfully treated with a state-of-the-art AI-powered device. A severe kind of pulmonary embolism known as pulmonary thromboembolism happens when a blood clot from the leg enters the bloodstream and lodges in the lungs. If left untreated, this illness can impair blood circulation and cause serious health issues or even death.
The patient had been experiencing symptoms for three days, including swelling in his left leg, breathing difficulty, and chest pain. He had attempted therapy at several hospitals without success. After a while, he reached Sir Gangaram Hospital, where Chairman of Vascular Surgery Dr. VS Bedi attended to him.
Dr. Bedi used a cutting-edge AI-powered tool that was made to precisely remove blood clots. Compared to conventional techniques, this innovative technology offers a substantial improvement in the treatment of deep vein thrombosis (DVT) and pulmonary embolism. The device’s artificial intelligence (AI) component improves its capacity to target only the clots, so minimizing the risk of removing normal blood and lowering the possibility of consequences including extreme blood loss and hypotension.
The standard therapy for pulmonary embolism frequently entails risky operations. These may involve the use of thrombolytic medications or the implantation of an inferior vena cava (IVC) filter, both of which have significant dangers that include internal bleeding into the brain, intestines, and other organs. By operating similarly to a vacuum cleaner, the AI-powered gadget provides a safer substitute by removing the clots without destroying the surrounding good blood.
Thrombosuction, a technique at Sir Gangaram Hospital that effectively removes clots with little blood loss, was performed using an AI device. This technique minimizes the likelihood of related adverse effects and greatly diminishes the necessity for more invasive procedures. Following the surgery, the patient’s condition quickly improved, proving the efficacy of this novel approach.
This gadget, which uses artificial intelligence (AI) to handle serious illnesses like pulmonary thromboembolism, represents a revolutionary stride in the field. This technique presents a possible alternative to conventional, riskier treatments by increasing precision and lowering risks, perhaps improving outcomes for patients with major blood clot problems.
